{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:28:03Z","timestamp":1784194083630,"version":"3.55.0"},"reference-count":22,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,12,1]]},"abstract":"<jats:p>BACKGROUND. Some children who present with fever and erythroderma have rapid clinical deterioration or progress to toxic shock syndrome. Our primary objective was to determine whether specific clinical features of those who present with fever and erythroderma can predict who will develop hypotension or progress to toxic shock syndrome. Our secondary objective was to describe the clinical presentation, course, and outcome of children with fever and erythroderma.<\/jats:p><jats:p>METHODS. We conducted a medical chart review of children \u226419 years of age with fever and erythroderma who presented to an urban pediatric emergency department over 60 months. Historical, clinical, and laboratory data were abstracted from the medical chart.<\/jats:p><jats:p>RESULTS. Fifty-six patients with fever and erythroderma were studied. Eighteen percent of patients presented with hypotension. Thirty-three percent of the remaining patients who were normotensive on arrival developed shock. Fifty-two percent of patients with hypotension required vasopressor support. The most important predictors of developing hypotension after presentation were: age \u22653 years, ill appearance, vomiting, glucose \u2265110 mg\/dL, calcium \u22648.6 mg\/dL, platelets \u2264300000\/\u03bcL, elevated creatinine, polymorphonuclear leukocytes \u226580%, and presence of a focal infection. Among all patients studied, 4 variables were determined to be the most important predictors of developing toxic shock syndrome: age \u22653 years, ill appearance, elevated creatinine, and hypotension on arrival.<\/jats:p><jats:p>CONCLUSIONS. Overall, 45% of patients with fever and erythroderma developed shock, including 33% of those who were normotensive on presentation. Older age, presence of vomiting, identification of a focal bacterial source, as well as specific laboratory parameters can be used to help predict which patients are likely to have hemodynamic deterioration. Given the high rate of clinical decompensation, all of the patients with fever and erythroderma should be hospitalized, closely monitored, and managed aggressively.<\/jats:p>","DOI":"10.1542\/peds.2006-1515","type":"journal-article","created":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T17:33:20Z","timestamp":1164994400000},"page":"2450-2460","source":"Crossref","is-referenced-by-count":10,"title":["Clinical Deterioration Among Patients With Fever and Erythroderma"],"prefix":"10.1542","volume":"118","author":[{"given":"Robyn L.","family":"Byer","sequence":"first","affiliation":[{"name":"Division of Emergency Medicine, Children's Hospital, Boston, Massachusetts; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard G.","family":"Bachur","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Children's Hospital, Boston, Massachusetts; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,12,1]]},"reference":[{"key":"2021120823130917700_R1","unstructured":"Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Recomm Rep.\u20081997;46(RR-10):1\u201355"},{"key":"2021120823130917700_R2","unstructured":"Gaushche-Hill M, Fuchs S, Yamamoto L, eds. The Pediatric Emergency Medicine Resource. 4th ed. Sudbury, MA: Jones and Bartlett Publishers; 2004."},{"key":"2021120823130917700_R3","unstructured":"Avner ED, Harmon WE, Niaudet P, eds. Pediatric Neprology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2004"},{"key":"2021120823130917700_R4","unstructured":"Schachner LA, Hansen RC. Pediatric Dermatology. 2nd ed. New York, NY: Churchill Livingstone; 1996"},{"key":"2021120823130917700_R5","doi-asserted-by":"crossref","unstructured":"Todd J, Fishaut M, Kapral F, Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet.\u20081978;2(8100):1116\u20131118","DOI":"10.1016\/S0140-6736(78)92274-2"},{"key":"2021120823130917700_R6","unstructured":"Chesney PJ, Chesney RW, Purdy W, Wand PJ, Chesney RW. Toxic-shock syndrome: United States. MMWR Morb Mortal Wkly Rep.\u20081980;29:229\u2013230"},{"key":"2021120823130917700_R7","unstructured":"Centers for Disease Control and Prevention. Follow-up on toxic-shock syndrome. MMWR Morb Mortal Wkly Rep.\u20081980;29:441\u2013445"},{"key":"2021120823130917700_R8","unstructured":"Centers for Disease Control and Prevention. Follow-up on toxic-shock syndrome: United States. MMWR Morb Mortal Wkly Rep.\u20081980;29:297\u2013299"},{"key":"2021120823130917700_R9","doi-asserted-by":"crossref","unstructured":"Davis JP, Chesney PJ, Wand PJ, LaVenture M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med.\u20081980;303:1429\u20131435","DOI":"10.1056\/NEJM198012183032501"},{"key":"2021120823130917700_R10","doi-asserted-by":"crossref","unstructured":"Schlech WF 3rd, Shands KN, Reingold AL, et al. Risk factors for development of toxic shock syndrome: association with a tampon brand. JAMA.\u20081982;248:835\u2013839","DOI":"10.1001\/jama.248.7.835"},{"key":"2021120823130917700_R11","doi-asserted-by":"crossref","unstructured":"Shands KN, Schlech WF 3rd, Hargrett NT, Dan BB, Schmid GP, Bennett JV. Toxic shock syndrome: case-control studies at the Centers for Disease Control. Ann Intern Med.\u20081982;96:895\u2013898","DOI":"10.7326\/0003-4819-96-6-895"},{"key":"2021120823130917700_R12","doi-asserted-by":"crossref","unstructured":"Shands KN, Schmid GP, Dan BB, et al. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med.\u20081980;303:1436\u20131442","DOI":"10.1056\/NEJM198012183032502"},{"key":"2021120823130917700_R13","doi-asserted-by":"crossref","unstructured":"Hajjeh RA, Reingold A, Weil A, Shutt K, Schuchat A, Perkins BA. Toxic shock syndrome in the United States: surveillance update, 1979 1996. Emerg Infect Dis.\u20081999;5:807\u2013810","DOI":"10.3201\/eid0506.990611"},{"key":"2021120823130917700_R14","doi-asserted-by":"crossref","unstructured":"Laupland KB, Davies HD, Low DE, Schwartz B, Green K, McGeer A. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group. Pediatrics.\u20082000;105(5). Available at: www.pediatrics.org\/cgi\/content\/full\/105\/5\/e60","DOI":"10.1542\/peds.105.5.e60"},{"key":"2021120823130917700_R15","doi-asserted-by":"crossref","unstructured":"Doctor A, Harper MB, Fleisher GR. Group A beta-hemolytic streptococcal bacteremia: historical overview, changing incidence, and recent association with varicella. Pediatrics.\u20081995;96:428\u2013433","DOI":"10.1542\/peds.96.3.428"},{"key":"2021120823130917700_R16","doi-asserted-by":"crossref","unstructured":"Chuang YY, Huang YC, Lin TY. Toxic shock syndrome in children: epidemiology, pathogenesis, and management. Paediatr Drugs.\u20082005;7:11\u201325","DOI":"10.2165\/00148581-200507010-00002"},{"key":"2021120823130917700_R17","doi-asserted-by":"crossref","unstructured":"Wharton M, Chorba TL, Vogt RL, Morse DL, Buehler JW. Case definitions for public health surveillance. MMWR Recomm Rep.\u20081990;39(RR-13):1\u201343","DOI":"10.1037\/e546082006-001"},{"key":"2021120823130917700_R18","doi-asserted-by":"crossref","unstructured":"Chesney PJ. Clinical aspects and spectrum of illness of toxic shock syndrome: overview. Rev Infect Dis.\u20081989;11(suppl 1):S1\u2013S7","DOI":"10.1093\/clinids\/11.Supplement_1.S1"},{"key":"2021120823130917700_R19","doi-asserted-by":"crossref","unstructured":"Wiesenthal AM, Todd JK. Toxic shock syndrome in children aged 10 years or less. Pediatrics.\u20081984;74:112\u2013117","DOI":"10.1542\/peds.74.1.112"},{"key":"2021120823130917700_R20","doi-asserted-by":"crossref","unstructured":"Spearman PW, Barson WJ. Toxic shock syndrome occurring in children with abrasive injuries beneath casts. J Pediatr Orthop.\u20081992;12:169\u2013172","DOI":"10.1097\/01241398-199203000-00005"},{"key":"2021120823130917700_R21","doi-asserted-by":"crossref","unstructured":"Chiang MC, Jaing TH, Wu CT, Hsia SH, Chiu CH. Streptococcal toxic shock syndrome in children without skin and soft tissue infection: report of four cases. Acta Paediatr.\u20082005;94:763\u2013765","DOI":"10.1111\/j.1651-2227.2005.tb01979.x"},{"key":"2021120823130917700_R22","doi-asserted-by":"crossref","unstructured":"Ferguson MA, Todd JK. Toxic shock syndrome associated with Staphylococcus aureus sinusitis in children. J Infect Dis.\u20081990;161:953\u2013955","DOI":"10.1093\/infdis\/161.5.953"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/6\/2450\/1118012\/zpe01206002450.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/6\/2450\/1118012\/zpe01206002450.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T21:41:51Z","timestamp":1683668511000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/6\/2450\/69747\/Clinical-Deterioration-Among-Patients-With-Fever"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,1]]},"references-count":22,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2006,12,1]]},"published-print":{"date-parts":[[2006,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-1515","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,1]]}}}